id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S9751 R34818 |
Borthen (Carbamazepine) (Controls exposed to Lamotrigine, sick), 2010 | Operative vaginal delivery (including vaginal breech delivery, forceps and vacuum delivery) | during pregnancy (anytime or not specified) | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: No |
0.76 [0.46;1.25] C excluded (control group) |
39/388 30/233 | 69 | 388 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S9753 R34826 |
Borthen (Carbamazepine) (Controls unexposed, disease free), 2010 | Operative vaginal delivery (including vaginal breech delivery, forceps and vacuum delivery) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes |
1.10 [0.80;1.60] excluded (control group) |
39/388 28,546/362,302 | 28,585 | 388 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S9755 R34834 |
Borthen (Carbamazepine) (Controls unexposed, sick), 2010 | Operative vaginal delivery (including vaginal breech delivery, forceps and vacuum delivery) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: No | 1.23 [0.85;1.78] C | 39/388 155/1,863 | 194 | 388 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S9615 R34165 |
Endo (Carbamazepine) (Controls unexposed, disease free), 2004 | Forceps deliveries | throughout pregnancy | retrospective cohort | unexposed, disease free excluded | Adjustment: No |
0.75 [0.04;13.33] C excluded (control group) |
0/8 53/656 | 53 | 8 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S9616 R34180 |
Endo (Carbamazepine) (Controls unexposed, sick), 2004 | Forceps deliveries | throughout pregnancy | retrospective cohort | unexposed, sick | Adjustment: No | 0.07 [0.00;8.55] C | 0/8 0/1 | 0 | 8 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 2 studies | 0.82 [0.11;5.98] | 194 | 396 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Carbamazepine) (Controls unexposed, sick; 2: Carbamazepine) (Controls unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 9615, 9751, 9753